arrow
C

Candelaria Gomez-Manzano

md anderson cancer center
H指数:52
被引数:1.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

PACM-04 ONCOLYTIC ADENOVIRUS RGDOX INDUCES SYSTEMIC CD8+ T CELL–MEDIATED IMMUNITY ACROSS INTRACRANIAL MELANOMA METASTASES: RATIONALE FOR A PHASE I TRIAL

PACM-04 溶瘤腺病毒RGDOX在颅内黑色素瘤转移中诱导系统性CD8+ T细胞介导的免疫反应:I期临床试验的依据

2026-08-070
OA
Microbial signals in primary and metastatic brain tumors

原发性和转移性脑肿瘤中的微生物信号

2025-11-140
OAAI
EXTH-106. Oncolytic adenovirus armed with immune stimulators: a promising partner for CAR T cell therapy in primary and metastatic malignant brain tumors

EXTH-106. 装载免疫刺激剂的溶瘤腺病毒:原发性及转移性恶性脑肿瘤中CAR T细胞疗法的有前景的合作伙伴

2025-11-110
OA
The oncolytic adenovirus Delta-24-RGD achieves antitumor polarization of the chordoma tumor microenvironment in human and murine models of chordoma

溶瘤腺病毒Delta-24-RGD在人类和鼠类脊索瘤模型中实现对脊索瘤肿瘤微环境的抗肿瘤极化

2025-11-010
OAAI
The oncolytic adenovirus RGDOX sensitizes the anti-tumor efficacy of immune checkpoint blockades in murine melanoma brain metastases models

溶瘤腺病毒RGDOX增强免疫检查点阻断在鼠黑色素瘤脑转移模型中的抗肿瘤疗效

2025-11-010
OAAI
A New View of Microvascular Proliferation: PDGFRB plus Perivascular Stromal Cells Drive MVP Formation, Immunosuppression and Stemness in Glioblastoma

微血管增殖的新视角:PDGFRB阳性周血管基质细胞驱动胶质母细胞瘤中的MVP形成、免疫抑制和干细胞特性

2025-11-010
PRE
T cell receptor diversity is a predictor of therapy response in patients with gliomas treated with Delta-24-RGD

T细胞受体多样性是接受Delta-24-RGD治疗的胶质瘤患者的治疗效果预测因子。

2025-11-010
PRE
Ruxolitinib enhances viroimmunotherapy of gliomas: targeting JAK-guided immunosuppressive pathways

鲁索利替尼增强胶质瘤的病毒免疫疗法:靶向JAK介导的免疫抑制通路

2025-11-010
OAAI
PHASE I TRIAL OF SINGLE INTRATUMORAL INJECTION OF DNX-2440 ONCOLYTIC ADENOVIRUS IN RECURRENT GLIOBLASTOMA PATIENTS

I期临床试验:DNX-2440 溶瘤腺病毒单次瘤内注射在复发胶质母细胞瘤患者中的应用

2025-11-010
OAAI
Author Correction: Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial

作者更正: 溶瘤DNX-2401病毒疗法联合pembrolizumab治疗复发性胶质母细胞瘤: 1/2期试验

2025-07-210
OA
Targeting the CD40 costimulatory receptor to improve virotherapy efficacy in diffuse midline gliomas

靶向CD40协同刺激受体以改善弥漫性中线胶质瘤的病毒治疗效果

2025-06-260
OAAI